nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—Alzheimer's disease—amyotrophic lateral sclerosis	0.573	1	CtDrD
Donepezil—SIGMAR1—amyotrophic lateral sclerosis	0.324	1	CbGaD
Donepezil—Erythropenia—Riluzole—amyotrophic lateral sclerosis	0.0056	0.0724	CcSEcCtD
Donepezil—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0041	0.204	CbGeAlD
Donepezil—HRH3—hindbrain—amyotrophic lateral sclerosis	0.00212	0.105	CbGeAlD
Donepezil—Iron deficiency anaemia—Riluzole—amyotrophic lateral sclerosis	0.00206	0.0266	CcSEcCtD
Donepezil—Major depression—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0224	CcSEcCtD
Donepezil—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0169	CcSEcCtD
Donepezil—Pyelonephritis—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0159	CcSEcCtD
Donepezil—HRH3—brainstem—amyotrophic lateral sclerosis	0.00121	0.0603	CbGeAlD
Donepezil—Dementia—Riluzole—amyotrophic lateral sclerosis	0.00114	0.0147	CcSEcCtD
Donepezil—Fungal skin infection—Riluzole—amyotrophic lateral sclerosis	0.00112	0.0144	CcSEcCtD
Donepezil—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.00108	0.0139	CcSEcCtD
Donepezil—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00107	0.0531	CbGeAlD
Donepezil—HTR2A—pons—amyotrophic lateral sclerosis	0.00106	0.0524	CbGeAlD
Donepezil—Hernia—Riluzole—amyotrophic lateral sclerosis	0.000996	0.0129	CcSEcCtD
Donepezil—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.000966	0.0125	CcSEcCtD
Donepezil—Peripheral vascular disorder—Riluzole—amyotrophic lateral sclerosis	0.000952	0.0123	CcSEcCtD
Donepezil—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.000938	0.0121	CcSEcCtD
Donepezil—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.000925	0.0119	CcSEcCtD
Donepezil—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.0009	0.0447	CbGeAlD
Donepezil—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000843	0.0109	CcSEcCtD
Donepezil—Hostility—Riluzole—amyotrophic lateral sclerosis	0.000843	0.0109	CcSEcCtD
Donepezil—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.000833	0.0108	CcSEcCtD
Donepezil—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.000823	0.0106	CcSEcCtD
Donepezil—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.000813	0.0105	CcSEcCtD
Donepezil—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.000803	0.0104	CcSEcCtD
Donepezil—HTR2A—appendage—amyotrophic lateral sclerosis	0.000772	0.0384	CbGeAlD
Donepezil—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.000767	0.00991	CcSEcCtD
Donepezil—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.000759	0.0098	CcSEcCtD
Donepezil—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.000743	0.00959	CcSEcCtD
Donepezil—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000713	0.0092	CcSEcCtD
Donepezil—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.000713	0.0092	CcSEcCtD
Donepezil—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.000702	0.0349	CbGeAlD
Donepezil—Cyst—Riluzole—amyotrophic lateral sclerosis	0.000698	0.00902	CcSEcCtD
Donepezil—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.000692	0.00893	CcSEcCtD
Donepezil—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.000685	0.00885	CcSEcCtD
Donepezil—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.000678	0.00876	CcSEcCtD
Donepezil—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.000678	0.00876	CcSEcCtD
Donepezil—Ileus—Riluzole—amyotrophic lateral sclerosis	0.00066	0.00852	CcSEcCtD
Donepezil—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00066	0.00852	CcSEcCtD
Donepezil—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.000654	0.00844	CcSEcCtD
Donepezil—Apathy—Riluzole—amyotrophic lateral sclerosis	0.000654	0.00844	CcSEcCtD
Donepezil—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.000648	0.00837	CcSEcCtD
Donepezil—HRH3—nervous system—amyotrophic lateral sclerosis	0.000636	0.0316	CbGeAlD
Donepezil—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00062	0.00801	CcSEcCtD
Donepezil—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00062	0.00801	CcSEcCtD
Donepezil—HRH3—central nervous system—amyotrophic lateral sclerosis	0.000613	0.0304	CbGeAlD
Donepezil—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.0006	0.00774	CcSEcCtD
Donepezil—HRH3—cerebellum—amyotrophic lateral sclerosis	0.000599	0.0298	CbGeAlD
Donepezil—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00059	0.00762	CcSEcCtD
Donepezil—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.000576	0.00744	CcSEcCtD
Donepezil—ACHE—Acetylcholine Synthesis—CHAT—amyotrophic lateral sclerosis	0.000568	0.101	CbGpPWpGaD
Donepezil—HTR2A—nerve—amyotrophic lateral sclerosis	0.000547	0.0272	CbGeAlD
Donepezil—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.000528	0.00681	CcSEcCtD
Donepezil—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.000517	0.00668	CcSEcCtD
Donepezil—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.000513	0.00663	CcSEcCtD
Donepezil—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.000513	0.00663	CcSEcCtD
Donepezil—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00051	0.00659	CcSEcCtD
Donepezil—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.000503	0.0065	CcSEcCtD
Donepezil—Gout—Riluzole—amyotrophic lateral sclerosis	0.0005	0.00646	CcSEcCtD
Donepezil—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.000497	0.00642	CcSEcCtD
Donepezil—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.000494	0.00637	CcSEcCtD
Donepezil—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.000494	0.00637	CcSEcCtD
Donepezil—Cataract—Riluzole—amyotrophic lateral sclerosis	0.000491	0.00633	CcSEcCtD
Donepezil—HRH3—brain—amyotrophic lateral sclerosis	0.000486	0.0242	CbGeAlD
Donepezil—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.000478	0.00618	CcSEcCtD
Donepezil—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.000467	0.00603	CcSEcCtD
Donepezil—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.000461	0.00596	CcSEcCtD
Donepezil—ACHE—medulla oblongata—amyotrophic lateral sclerosis	0.000458	0.0228	CbGeAlD
Donepezil—Melaena—Riluzole—amyotrophic lateral sclerosis	0.000456	0.00589	CcSEcCtD
Donepezil—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.000451	0.00582	CcSEcCtD
Donepezil—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.000429	0.00554	CcSEcCtD
Donepezil—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.000422	0.00545	CcSEcCtD
Donepezil—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00041	0.0204	CbGeAlD
Donepezil—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.000409	0.00529	CcSEcCtD
Donepezil—ACHE—spinal cord—amyotrophic lateral sclerosis	0.000409	0.0203	CbGeAlD
Donepezil—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.000405	0.00523	CcSEcCtD
Donepezil—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.000401	0.00518	CcSEcCtD
Donepezil—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.000397	0.00513	CcSEcCtD
Donepezil—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00039	0.00503	CcSEcCtD
Donepezil—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00039	0.00503	CcSEcCtD
Donepezil—Eczema—Riluzole—amyotrophic lateral sclerosis	0.000377	0.00487	CcSEcCtD
Donepezil—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.000374	0.00483	CcSEcCtD
Donepezil—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000373	0.0186	CbGeAlD
Donepezil—Injury—Riluzole—amyotrophic lateral sclerosis	0.000369	0.00476	CcSEcCtD
Donepezil—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.000365	0.00472	CcSEcCtD
Donepezil—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.000361	0.00466	CcSEcCtD
Donepezil—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.000358	0.00462	CcSEcCtD
Donepezil—Thirst—Riluzole—amyotrophic lateral sclerosis	0.000356	0.0046	CcSEcCtD
Donepezil—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.000349	0.0045	CcSEcCtD
Donepezil—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.000347	0.00448	CcSEcCtD
Donepezil—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00034	0.00439	CcSEcCtD
Donepezil—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000339	0.00438	CcSEcCtD
Donepezil—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000339	0.00438	CcSEcCtD
Donepezil—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.000336	0.00434	CcSEcCtD
Donepezil—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000334	0.00431	CcSEcCtD
Donepezil—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.000331	0.00427	CcSEcCtD
Donepezil—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.000327	0.00423	CcSEcCtD
Donepezil—ACHE—cerebellum—amyotrophic lateral sclerosis	0.000324	0.0161	CbGeAlD
Donepezil—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.000322	0.00416	CcSEcCtD
Donepezil—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000321	0.00415	CcSEcCtD
Donepezil—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.000319	0.00412	CcSEcCtD
Donepezil—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.000315	0.00407	CcSEcCtD
Donepezil—HRH3—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.000313	0.0558	CbGpPWpGaD
Donepezil—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.000313	0.00404	CcSEcCtD
Donepezil—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00031	0.004	CcSEcCtD
Donepezil—ACHE—Biogenic Amine Synthesis—CHAT—amyotrophic lateral sclerosis	0.000308	0.055	CbGpPWpGaD
Donepezil—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.000308	0.00398	CcSEcCtD
Donepezil—SIGMAR1—medulla oblongata—amyotrophic lateral sclerosis	0.000307	0.0153	CbGeAlD
Donepezil—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000305	0.00394	CcSEcCtD
Donepezil—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.0003	0.00387	CcSEcCtD
Donepezil—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000299	0.00386	CcSEcCtD
Donepezil—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.000299	0.00386	CcSEcCtD
Donepezil—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.000295	0.00381	CcSEcCtD
Donepezil—Asthma—Riluzole—amyotrophic lateral sclerosis	0.000293	0.00378	CcSEcCtD
Donepezil—Influenza—Riluzole—amyotrophic lateral sclerosis	0.000293	0.00378	CcSEcCtD
Donepezil—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.000293	0.00378	CcSEcCtD
Donepezil—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000287	0.00371	CcSEcCtD
Donepezil—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.000285	0.00368	CcSEcCtD
Donepezil—ACHE—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000282	0.0503	CbGpPWpGaD
Donepezil—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.000282	0.00364	CcSEcCtD
Donepezil—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000281	0.00363	CcSEcCtD
Donepezil—SIGMAR1—spinal cord—amyotrophic lateral sclerosis	0.000274	0.0136	CbGeAlD
Donepezil—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.000274	0.00354	CcSEcCtD
Donepezil—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.000271	0.00349	CcSEcCtD
Donepezil—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000267	0.00344	CcSEcCtD
Donepezil—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000265	0.00342	CcSEcCtD
Donepezil—ACHE—brain—amyotrophic lateral sclerosis	0.000263	0.0131	CbGeAlD
Donepezil—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000263	0.00339	CcSEcCtD
Donepezil—Infestation—Riluzole—amyotrophic lateral sclerosis	0.000261	0.00337	CcSEcCtD
Donepezil—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.000261	0.00337	CcSEcCtD
Donepezil—Depression—Riluzole—amyotrophic lateral sclerosis	0.00026	0.00336	CcSEcCtD
Donepezil—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.000257	0.00332	CcSEcCtD
Donepezil—HTR2A—embryo—amyotrophic lateral sclerosis	0.000256	0.0127	CbGeAlD
Donepezil—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000256	0.00331	CcSEcCtD
Donepezil—ACHE—Synthesis of PC—CHAT—amyotrophic lateral sclerosis	0.000255	0.0455	CbGpPWpGaD
Donepezil—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.000255	0.00329	CcSEcCtD
Donepezil—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.000254	0.00328	CcSEcCtD
Donepezil—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00025	0.00323	CcSEcCtD
Donepezil—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000249	0.00322	CcSEcCtD
Donepezil—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000246	0.00318	CcSEcCtD
Donepezil—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000239	0.00308	CcSEcCtD
Donepezil—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000236	0.00304	CcSEcCtD
Donepezil—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000235	0.00304	CcSEcCtD
Donepezil—HTR2A—brainstem—amyotrophic lateral sclerosis	0.000235	0.0117	CbGeAlD
Donepezil—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000234	0.00303	CcSEcCtD
Donepezil—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000234	0.00303	CcSEcCtD
Donepezil—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000233	0.00301	CcSEcCtD
Donepezil—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000233	0.00301	CcSEcCtD
Donepezil—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000233	0.00301	CcSEcCtD
Donepezil—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000232	0.00299	CcSEcCtD
Donepezil—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000231	0.00298	CcSEcCtD
Donepezil—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00023	0.00297	CcSEcCtD
Donepezil—SIGMAR1—cerebellum—amyotrophic lateral sclerosis	0.000217	0.0108	CbGeAlD
Donepezil—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000214	0.0106	CbGeAlD
Donepezil—Chills—Riluzole—amyotrophic lateral sclerosis	0.00021	0.00272	CcSEcCtD
Donepezil—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000209	0.0027	CcSEcCtD
Donepezil—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000207	0.00268	CcSEcCtD
Donepezil—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000205	0.00265	CcSEcCtD
Donepezil—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000204	0.00264	CcSEcCtD
Donepezil—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000201	0.0026	CcSEcCtD
Donepezil—Tension—Riluzole—amyotrophic lateral sclerosis	0.0002	0.00259	CcSEcCtD
Donepezil—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.0002	0.00258	CcSEcCtD
Donepezil—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000198	0.00256	CcSEcCtD
Donepezil—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000197	0.00255	CcSEcCtD
Donepezil—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000196	0.00253	CcSEcCtD
Donepezil—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000191	0.00247	CcSEcCtD
Donepezil—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000189	0.00245	CcSEcCtD
Donepezil—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000189	0.00244	CcSEcCtD
Donepezil—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000188	0.00242	CcSEcCtD
Donepezil—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000184	0.00238	CcSEcCtD
Donepezil—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000183	0.00237	CcSEcCtD
Donepezil—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000183	0.00236	CcSEcCtD
Donepezil—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000179	0.00232	CcSEcCtD
Donepezil—Cough—Riluzole—amyotrophic lateral sclerosis	0.000178	0.0023	CcSEcCtD
Donepezil—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000177	0.00228	CcSEcCtD
Donepezil—SIGMAR1—brain—amyotrophic lateral sclerosis	0.000177	0.00877	CbGeAlD
Donepezil—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000176	0.00228	CcSEcCtD
Donepezil—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000174	0.00224	CcSEcCtD
Donepezil—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000174	0.00224	CcSEcCtD
Donepezil—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000174	0.00224	CcSEcCtD
Donepezil—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000173	0.00224	CcSEcCtD
Donepezil—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000172	0.00222	CcSEcCtD
Donepezil—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00017	0.00219	CcSEcCtD
Donepezil—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000168	0.00217	CcSEcCtD
Donepezil—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000167	0.00215	CcSEcCtD
Donepezil—Infection—Riluzole—amyotrophic lateral sclerosis	0.000165	0.00214	CcSEcCtD
Donepezil—Shock—Riluzole—amyotrophic lateral sclerosis	0.000164	0.00212	CcSEcCtD
Donepezil—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.000164	0.00814	CbGeAlD
Donepezil—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000163	0.00211	CcSEcCtD
Donepezil—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000163	0.00211	CcSEcCtD
Donepezil—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000161	0.00208	CcSEcCtD
Donepezil—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000159	0.00205	CcSEcCtD
Donepezil—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000156	0.00201	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000152	0.00196	CcSEcCtD
Donepezil—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000151	0.00195	CcSEcCtD
Donepezil—ACHE—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.00015	0.0267	CbGpPWpGaD
Donepezil—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00015	0.00193	CcSEcCtD
Donepezil—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000149	0.00192	CcSEcCtD
Donepezil—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000148	0.00191	CcSEcCtD
Donepezil—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000147	0.00189	CcSEcCtD
Donepezil—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000146	0.00726	CbGeAlD
Donepezil—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000145	0.00187	CcSEcCtD
Donepezil—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000144	0.00186	CcSEcCtD
Donepezil—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000144	0.00185	CcSEcCtD
Donepezil—Pain—Riluzole—amyotrophic lateral sclerosis	0.000142	0.00184	CcSEcCtD
Donepezil—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000142	0.00184	CcSEcCtD
Donepezil—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000137	0.00177	CcSEcCtD
Donepezil—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000136	0.00176	CcSEcCtD
Donepezil—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000132	0.00171	CcSEcCtD
Donepezil—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000132	0.0017	CcSEcCtD
Donepezil—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000132	0.0017	CcSEcCtD
Donepezil—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.000124	0.0221	CbGpPWpGaD
Donepezil—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000123	0.00611	CbGeAlD
Donepezil—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000123	0.00158	CcSEcCtD
Donepezil—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00012	0.00154	CcSEcCtD
Donepezil—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000118	0.00589	CbGeAlD
Donepezil—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000118	0.00152	CcSEcCtD
Donepezil—CYP2D6—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000116	0.0206	CbGpPWpGaD
Donepezil—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000116	0.00575	CbGeAlD
Donepezil—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000114	0.00147	CcSEcCtD
Donepezil—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000114	0.00566	CbGeAlD
Donepezil—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000112	0.00557	CbGeAlD
Donepezil—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00011	0.00142	CcSEcCtD
Donepezil—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00011	0.00545	CbGeAlD
Donepezil—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000108	0.00536	CbGeAlD
Donepezil—ACHE—Phospholipid metabolism—SACM1L—amyotrophic lateral sclerosis	0.000107	0.0191	CbGpPWpGaD
Donepezil—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000106	0.00137	CcSEcCtD
Donepezil—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000106	0.00524	CbGeAlD
Donepezil—Rash—Riluzole—amyotrophic lateral sclerosis	0.000105	0.00136	CcSEcCtD
Donepezil—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000105	0.00136	CcSEcCtD
Donepezil—Headache—Riluzole—amyotrophic lateral sclerosis	0.000104	0.00135	CcSEcCtD
Donepezil—ACHE—Phospholipid metabolism—FIG4—amyotrophic lateral sclerosis	0.000101	0.0179	CbGpPWpGaD
Donepezil—Nausea—Riluzole—amyotrophic lateral sclerosis	9.89e-05	0.00128	CcSEcCtD
Donepezil—ACHE—Glycerophospholipid biosynthesis—PLB1—amyotrophic lateral sclerosis	9.88e-05	0.0176	CbGpPWpGaD
Donepezil—HTR2A—brain—amyotrophic lateral sclerosis	9.41e-05	0.00467	CbGeAlD
Donepezil—ACHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—amyotrophic lateral sclerosis	9.37e-05	0.0167	CbGpPWpGaD
Donepezil—CYP2D6—brain—amyotrophic lateral sclerosis	8.57e-05	0.00426	CbGeAlD
Donepezil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	8.25e-05	0.0147	CbGpPWpGaD
Donepezil—ACHE—Glycerophospholipid biosynthesis—CHAT—amyotrophic lateral sclerosis	7.49e-05	0.0133	CbGpPWpGaD
Donepezil—ACHE—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	7.4e-05	0.0132	CbGpPWpGaD
Donepezil—HRH3—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	7.13e-05	0.0127	CbGpPWpGaD
Donepezil—ACHE—Phospholipid metabolism—PLB1—amyotrophic lateral sclerosis	6.9e-05	0.0123	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	6.25e-05	0.0111	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	5.67e-05	0.0101	CbGpPWpGaD
Donepezil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	5.44e-05	0.00969	CbGpPWpGaD
Donepezil—ACHE—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	5.23e-05	0.00931	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	5.12e-05	0.00913	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	5.1e-05	0.00908	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	5.09e-05	0.00906	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	4.73e-05	0.00843	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	4.62e-05	0.00823	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	4.57e-05	0.00814	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	4.32e-05	0.0077	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	4.18e-05	0.00744	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.05e-05	0.00722	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	3.93e-05	0.007	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	3.88e-05	0.00692	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	3.88e-05	0.00692	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.71e-05	0.0066	CbGpPWpGaD
Donepezil—ACHE—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	3.7e-05	0.00659	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—GRIA2—amyotrophic lateral sclerosis	3.62e-05	0.00646	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	3.51e-05	0.00625	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	3.5e-05	0.00624	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	3.5e-05	0.00624	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	3.46e-05	0.00617	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.45e-05	0.00614	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	3.4e-05	0.00606	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	3.28e-05	0.00584	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	3.28e-05	0.00584	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	3.28e-05	0.00584	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.24e-05	0.00577	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	3.2e-05	0.00571	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	3.2e-05	0.0057	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—NEFL—amyotrophic lateral sclerosis	3.2e-05	0.0057	CbGpPWpGaD
Donepezil—HRH3—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	3.11e-05	0.00555	CbGpPWpGaD
Donepezil—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	3.03e-05	0.00541	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	2.98e-05	0.0053	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	2.98e-05	0.0053	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	2.65e-05	0.00473	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	2.65e-05	0.00473	CbGpPWpGaD
Donepezil—ACHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	2.59e-05	0.00461	CbGpPWpGaD
Donepezil—ACHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.58e-05	0.0046	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	2.48e-05	0.00441	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	2.47e-05	0.00441	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	2.44e-05	0.00435	CbGpPWpGaD
Donepezil—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.36e-05	0.00421	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.22e-05	0.00396	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	2.22e-05	0.00395	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	2.19e-05	0.00389	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	2.16e-05	0.00385	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	2.14e-05	0.00381	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	2.08e-05	0.00371	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	1.99e-05	0.00355	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—C3—amyotrophic lateral sclerosis	1.89e-05	0.00336	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	1.88e-05	0.00335	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	1.84e-05	0.00328	CbGpPWpGaD
Donepezil—ACHE—Metabolism—TPK1—amyotrophic lateral sclerosis	1.8e-05	0.00322	CbGpPWpGaD
Donepezil—ACHE—Metabolism—VAPB—amyotrophic lateral sclerosis	1.8e-05	0.00322	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.73e-05	0.00308	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	1.7e-05	0.00302	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.68e-05	0.003	CbGpPWpGaD
Donepezil—ACHE—Metabolism—VAPA—amyotrophic lateral sclerosis	1.65e-05	0.00294	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	1.65e-05	0.00294	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.62e-05	0.00289	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	1.56e-05	0.00279	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.54e-05	0.00274	CbGpPWpGaD
Donepezil—ACHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.53e-05	0.00273	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	1.51e-05	0.00269	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.49e-05	0.00266	CbGpPWpGaD
Donepezil—ACHE—Metabolism—FIG4—amyotrophic lateral sclerosis	1.44e-05	0.00257	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	1.43e-05	0.00255	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	1.41e-05	0.00251	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	1.4e-05	0.0025	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.35e-05	0.00241	CbGpPWpGaD
Donepezil—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	1.33e-05	0.00238	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.32e-05	0.00236	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	1.32e-05	0.00235	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.31e-05	0.00233	CbGpPWpGaD
Donepezil—ACHE—Metabolism—DAO—amyotrophic lateral sclerosis	1.3e-05	0.00232	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	1.16e-05	0.00206	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.12e-05	0.002	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.09e-05	0.00195	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.07e-05	0.0019	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.04e-05	0.00186	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PLB1—amyotrophic lateral sclerosis	9.89e-06	0.00176	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.68e-06	0.00172	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.66e-06	0.00172	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.58e-06	0.00171	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.53e-06	0.0017	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.44e-06	0.00168	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSR—amyotrophic lateral sclerosis	9.13e-06	0.00163	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	9.03e-06	0.00161	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9e-06	0.0016	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	8.84e-06	0.00157	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	8.47e-06	0.00151	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.44e-06	0.0015	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.31e-06	0.00148	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	8.2e-06	0.00146	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	8.08e-06	0.00144	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.04e-06	0.00143	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CHAT—amyotrophic lateral sclerosis	7.49e-06	0.00134	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	7.4e-06	0.00132	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	7.4e-06	0.00132	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	7.34e-06	0.00131	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	7.34e-06	0.00131	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	7.34e-06	0.00131	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	7.19e-06	0.00128	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.88e-06	0.00123	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.84e-06	0.00122	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.84e-06	0.00122	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	6.77e-06	0.00121	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	6.71e-06	0.0012	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	6.68e-06	0.00119	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.47e-06	0.00115	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.32e-06	0.00113	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.29e-06	0.00112	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	6.24e-06	0.00111	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.24e-06	0.00111	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.23e-06	0.00111	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	5.92e-06	0.00105	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	5.87e-06	0.00105	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	5.72e-06	0.00102	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.72e-06	0.00102	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	5.38e-06	0.000958	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	5.35e-06	0.000954	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.32e-06	0.000948	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	5.31e-06	0.000945	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	5.1e-06	0.000909	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	4.94e-06	0.00088	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	4.88e-06	0.00087	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	4.84e-06	0.000862	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	4.84e-06	0.000862	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.69e-06	0.000835	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	4.43e-06	0.000789	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.4e-06	0.000784	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	4.38e-06	0.000781	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	4.34e-06	0.000772	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.11e-06	0.000733	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	4.06e-06	0.000723	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.03e-06	0.000718	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	4.02e-06	0.000716	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	3.87e-06	0.000689	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	3.74e-06	0.000667	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	3.71e-06	0.000661	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.7e-06	0.000659	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	3.62e-06	0.000646	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	3.53e-06	0.000629	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	3.5e-06	0.000623	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.38e-06	0.000603	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.38e-06	0.000602	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.2e-06	0.000571	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.2e-06	0.00057	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.07e-06	0.000548	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	3.05e-06	0.000543	CbGpPWpGaD
Donepezil—ACHE—Metabolism—APOE—amyotrophic lateral sclerosis	3.05e-06	0.000543	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.98e-06	0.000531	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.87e-06	0.000512	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.79e-06	0.000498	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.78e-06	0.000495	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.66e-06	0.000474	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.65e-06	0.000472	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.45e-06	0.000436	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.28e-06	0.000406	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.17e-06	0.000387	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.14e-06	0.000382	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.09e-06	0.000372	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.01e-06	0.000358	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.91e-06	0.000339	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.89e-06	0.000337	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.76e-06	0.000314	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.65e-06	0.000294	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.64e-06	0.000292	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.52e-06	0.000271	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.5e-06	0.000268	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.46e-06	0.000259	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.25e-06	0.000223	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.24e-06	0.000221	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.12e-06	0.0002	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.08e-06	0.000192	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.06e-06	0.000189	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.93e-07	0.000177	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.51e-07	0.000169	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.56e-07	0.000152	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.48e-07	0.000151	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	8.17e-07	0.000146	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.18e-07	0.000128	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.6e-07	9.97e-05	CbGpPWpGaD
